Researchers at the Institute for Molecular Bioscience (IMB) at The University of Queensland (UQ) have initiated a research program to resurrect an old natural product antibiotic (colistin) that is active against resistant Gram-negative bacteria in vitro and in vivo, but was never synthesised nor clinically assessed.

UniQuest Contact: 

Mark Ashton

Executive Director, Intellectual Property Commercialisation
Mobile phone: 
+61 410 601 970
Work phone: 
+61 (7) 3365 4037